Carbamazepine behaviour and effects in an urban wastewater MBR working with high sludge and hydraulic retention time

References

• Ruhmland, S.; Wick, A.; Ternes, T.A.; Barjenbruch, M. Fate of pharmaceuticals in subsurface flow constructed wetland and two ponds. Ecol. Eng. 2015, 80, 125–139.
   Web of Science ®Google Scholar
• Binelli, A.; Magni, S.; Soave, C.; Marazzi, F.; Zuccato, E.; Castiglioni, S.; Parolini, M.; Mezzanotte, V. The biofiltration process by the bivalve D. polymorpha for the removalof some pharmaceuticals and drugs of abuse from civil wastewaters. Ecol. Eng. 2014, 71, 710–721.
   Web of Science ®Google Scholar
• Zhang, Y.; Geiben, S.; Gal, C. Cabamazepine and diclofenac: Removal in wastewater treatment plants and occurrence in water bodies, review. Chemosphere 2008, 73, 1151–1161.
   PubMed Web of Science ®Google Scholar
• Zhang, D.Q.; Tan, S.K.; Gersberg, R.; Sadreddini, S.; Zhu, J.; Tuan, N.A. Removal of pharmaceutical compounds in tropical constructed wetlands. Ecol. Eng. 2011, 37, 460–464.
   Web of Science ®Google Scholar
• Carranza-Díaz, O.; Schultze-Nobre, L.; Moeder, M.; Nivala, J.; Kuschk, P.; Koeser, H. Removal of selected organic micropollutants in planted and unplanted pilot-scale horizontal flow constructed wetlands under conditions of high organic load. Ecol. Eng. 2014, 71, 234–245.
   Web of Science ®Google Scholar
• Clara, M.; Strenn, B.; Gans, O.; Martinez, E.; Kreuzinger, N.; Kroiss, H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 2005, 39, 4797–4807.
   PubMed Web of Science ®Google Scholar
• Kim, S.D.; Cho J.; Kim I.S.; Vanderford B.J.; Snyder, S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korea surface, drinking and waste water. Water Res. 2007, 41, 1013–1021.
   PubMed Web of Science ®Google Scholar
• Vieno, N.; Tuhkanen, T.; Kronberg, L. Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res. 2007, 41, 1001–1012.
   PubMed Web of Science ®Google Scholar
• Bernhard, M.; Müller, J.; Knepper, T.P. Biodegradation of persistent polar pollutants in wastewater: Comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment. Water Res. 2006, 40, 3419–3428.
   PubMed Web of Science ®Google Scholar
• Zhou, X.F.; Dai, C.M.; Zhang, Y.L.; Surampalli, R.Y.; Zhang, T.C. A preliminary study on the occurrence and behavior of carbamazepine (CBZ) in aquatic environment of Yangtze River Delta, China. Environ. Monit. Assess. 2011, 173, 45–53.
   PubMed Web of Science ®Google Scholar
• Arévalo, J.; Ruiz, L.M.; Parada-Albarracín, J.A.; González-Pérez, D.M.; Pérez, J.; Moreno, B.; Gómez, M.A. Wastewater reuse after treatment by MBR. Microfiltration or ultrafiltration? Desalination 2012, 299, 22–27.
   Web of Science ®Google Scholar
• González-Pérez, D.M.; Garralón, G.; Plaza, F.; Pérez, J.; Moreno, B.; Gómez, M.A. Removal of low concentration of phenanthrene, fluoranthene and pyrene from urban wastewater by membrane bioreactors technology. J. Environ. Sci. Heal. A. 2012, 47, 2190–2197.
   PubMed Web of Science ®Google Scholar
• Santos, A.; Ma, W.; Judd, S. Membrane bioreactors: Two decades of research and implementation. Desalination 2010, 273, 148–154.
   Web of Science ®Google Scholar
• Aubenneau, M.; Tahar, A.; Casellas, C.; Wisniewski, C. Membrane bioreactor for pharmaceutically active compounds removal: Effects of carbamazepine on mixed microbial communities implied in the treatment. Process Biochem. 2010, 45, 1826–1831.
   Web of Science ®Google Scholar
• Maeng, S.K.; Choi, B.G.; Lee, K.T.; Song, K.G. Influences of solid retention time, nitrification and microbial activity on the attenuation of pharmaceuticals and estrogens in membrane bioreactors. Water Res. 2013, 47, 3151–3162.
   PubMed Web of Science ®Google Scholar
• Ahmed, F.N.; Lan, C.Q. Treatment of landfill leachate using membrane bioreactors: A review. Desalination 2012, 287, 41–54.
   Web of Science ®Google Scholar
• Radjenovic, J.; Petrovic, M.; Barceló, D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 2009, 43, 831–841.
   PubMed Web of Science ®Google Scholar
• Miller, C.; Hall, K.; Liang, Y.N.; Nieman, K.; Sorensen, D.L.; Issa, L.; Anderson, A.J.; Sims, R.C. Isolation and characterization of polycyclic aromatic hydrocarbon-degrading Mycobacterium isolates from soil. Microb. Ecol. 2004, 48, 230–238.
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency. Method 1694: Pharmaceuticals and Personal Care Products in Water, Soil, Sediment, and Biosolids by HPLC/MS/MS. US E.P.A.: Washington, D.C., 2007.
   Google Scholar
• APHA, AWWA, and WEF. Standard Methods for the Examination of Water and Wastewater, 22nd Ed.; American Public Health Association: Washington, D.C., 2012.
   Google Scholar
• Rojas, J.C.; Pérez, J.; Garralón, G.; Plaza, F.; Moreno, B.; Gómez, M.A. Humic acids removal by aerated spiral-wound ultrafiltration membrane combined with coagulation-flocculation. Desalination 2011, 266, 128–133.
   Web of Science ®Google Scholar
• Henriques, I.D.S.; Holbrook, R.D.; Kelly II, R.T.; Love, N.G. The impact of flocs size on respiration inhibition by soluble toxicants—a comparative investigation. Water Res. 2005, 39, 2559–2568.
   PubMed Web of Science ®Google Scholar
• Kraigher, B.; Kosjek, T.; Heath, E.; Kompare, B.; Mandic-Mulec, I. Influence of pharmaceutical residues on the structure of activated sludge bacterial communities in wastewater treatment bioreactors. Water Res. 2008, 42, 4578–88.
   PubMed Web of Science ®Google Scholar
• Al-Rifai, J.H.; Khabbaz, H.; Schäfer, A.I. Removal of pharmaceuticals and endocrine disrupting compounds in water recycling process using osmosis systems. Sep. Purif. Technol. 2011, 77, 60–67.
   Web of Science ®Google Scholar
• Castiglioni, S.; Bagnati, R.; Fanilli, R.; Pomati, F.; Calamari, D.; Zuccata, E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ. Sci. Technol. 2006, 40, 357–363.
   PubMed Web of Science ®Google Scholar
• Maggs, J.L.; Pirmohamed, M.; Kitteringham, N.R.; Park, B.K. Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography/mass spectrometry. Drug Metabol. Disposit. 1997, 25, 275–280.
   PubMed Web of Science ®Google Scholar
• Ternes, T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32, 3245–3260.
   Web of Science ®Google Scholar
• Miao, X.S.; Yang, J.J.; Metcalfe, C.D. Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environ. Sci. Technol. 2005, 39, 7469–7475.
   PubMed Web of Science ®Google Scholar
• Clara, M.; Strenn, B.; Kreuzinger, N. Carbamazepine as a possible anthropogenic marker in the aquatic environment: Investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration. Water Res. 2004, 38, 947–954.
   PubMed Web of Science ®Google Scholar